|
AU2018269194A1
|
|
Bicistronic chimeric antigen receptors and their uses
|
|
AU2017310513A1
|
|
Multi-dimensional spectroscopic NMR and MRI using marginal distributions
|
|
AU2017312499A1
|
|
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
|
|
AU2017281088A1
|
|
Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer
|
|
AU2017253935A1
|
|
Use of gram negative species to treat atopic dermatitis
|
|
AU2016311429A1
|
|
Modified anthrax toxin protective antigen
|
|
AU2016258845A1
|
|
Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
|
